Ketamine: The Benefits Continue to Unfold
Columbia University and Weill Cornell Medicine psychiatrists continue to investigate – in the clinic and in the lab – the potential role of ketamine in the treatment of resistant depression.
COVID-19: Causative Role in Psychosis, Depression, and Other Mental Health Conditions
With more than a year of observing the wide-ranging impact of COVID-19 on multiple organ systems, psychiatrists have acquired a growing knowledge base of short- and long-term neuropsychiatric symptoms and long-term brain sequelae.
Cognitive Flexibility: A New Understanding of the Prefrontal Cortex
Scientists know that the prefrontal cortex is essential in both humans and animals for shifting attention in response to changing circumstances.
Investigating the Neurobiological Mechanism for Hallucinations and Delusions
Researchers Kenneth Wengler, PhD and Guillermo Horga, MD, PhD have found evidence of a potential neurobiological mechanism for hallucinations and delusions that fit within the hierarchical model of psychosis and can explain their clinical presentation.
Recognizing Safety Signals May Reduce Fear and Anxiety
A study by investigators at Weill Cornell Medicine, NewYork-Presbyterian, and Yale University demonstrates that safety signals activate different circuits in the brain from those involved in typical anxiety therapy.
Dr. Vivian Pender: Upcoming President of APA
In May 2021, Vivian B. Pender, MD, Clinical Professor of Psychiatry at Weill Cornell Medicine and Lecturer in Psychoanalysis at Columbia University Vagelos College of Physicians and Surgeon, will assume the role as President of the American Psychiatric Association (APA).
Defining Unique Subtypes in Depression
In a quest to better define depression diagnosis, a neuroscientist and psychiatrist at NewYork-Presbyterian/Weill Cornell used fMRI brain scans to identify unique subtypes of depression.
The Role of Ketamine in Treatment-Resistant Depression
Dr. Mann and his Columbia colleagues have been investigating the use of ketamine as a treatment option for rapidly reducing suicidal thoughts in patients with refractory depression.
Page1 of 3